| Presented by: | The American Society of Health-System Pharmacists |
| Lecturer | Van Anh Trinh and Jamie Poust |
| Approximate duration: | Not available |
| Summary points: | In this text-based CME activity, the authors discuss the current approaches to melanoma therapy and the success rates and limitations of these treatments and explain the rationale for the use of monoclonal antibodies and other targeted biological therapies in melanoma care. |
| Accreditation: | The American Society of Health-System Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
The supplement as a whole provides 1.5 hours (0.15 CEUs) of continuing-education credit
(program number 204-000-08-009-H01P).
Expiration Date: December 15, 2011. |
| Other: | Text-only CE. |
Emerging Strategies for the Treatment of Metastatic Melanoma: The Role of Monoclonal Antibodies in Targeted Immunotherapy
